tiprankstipranks
Trending News
More News >
Takara Bio Inc. (JP:4974)
:4974
Japanese Market
Advertisement

Takara Bio Inc. (4974) Income Statement

Compare
2 Followers

Takara Bio Inc. Income Statement

Last quarter (Q4 2024), Takara Bio Inc.'s total revenue was ¥15.76B, an increase of 14.42% from the same quarter last year. In Q4, Takara Bio Inc.'s net income was ¥2.42B. See Takara Bio Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 45.04B¥ 43.51B¥ 78.14B¥ 67.70B¥ 46.09B
Gross Profit
¥ 26.07B¥ 26.91B¥ 44.77B¥ 49.21B¥ 31.87B
Operating Expenses
¥ 23.80B¥ 23.91B¥ 24.22B¥ 20.31B¥ 17.92B
Depreciation and Amortization
¥ 4.48B¥ 5.02B¥ 4.74B¥ 4.15B¥ 3.79B
EBITDA
¥ 6.50B¥ 7.90B¥ 25.28B¥ 33.05B¥ 17.74B
Operating Income
¥ 2.26B¥ 3.00B¥ 20.54B¥ 28.90B¥ 13.95B
Other Income/Expenses
¥ -266.00M¥ -150.00M¥ 683.00M¥ -1.37B¥ -400.00M
Pretax Income
¥ 2.00B¥ 2.85B¥ 21.22B¥ 27.53B¥ 13.55B
Net Income
¥ 1.04B¥ 1.48B¥ 16.01B¥ 19.85B¥ 9.55B
Per Share Metrics
Basic EPS
¥ 8.65¥ 12.29¥ 132.97¥ 164.84¥ 79.28
Diluted EPS
¥ 8.65¥ 12.29¥ 132.97¥ 164.84¥ 79.28
Weighted Average Shares Outstanding
120.42M 120.42M 120.42M 120.42M 120.42M
Weighted Average Shares Outstanding (Diluted)
120.42M 120.42M 120.42M 120.42M 120.42M
Currency in JPY

Takara Bio Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis